Emerging concern of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy

Conclusion: Incidence of infectious diseases was relatively high in patients with nivolumab treatment. ICI has a potential risk for infectious disease regardless of steroid use.

Source: European Respiratory Journal - December 6, 2017 Category: Respiratory Medicine Authors: Fujita, K., Kanai, O., Kim, Y. H., Yoshida, H., Mio, T., Hirai, T. Tags: Lung Cancer Source Type: research